Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug product selection: legal issues.

T P Christensen1, D M Kirking, F J Ascione

  • 1College of Pharmacy, North Dakota State University, Fargo 58105, USA. thomas.christensen@ndsu.nodak.edu

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Review article: diagnosis and management of night-time reflux.

Alimentary pharmacology & therapeutics·2004
Same author

Comparison of 3 vancomycin dosage regimens during hemodialysis with cellulose triacetate dialyzers: post-dialysis versus intradialytic administration.

Clinical nephrology·2003
Same author

Relationship between patient and disease characteristics, and health-related quality of life in adults with asthma.

Respiratory medicine·2002
Same author

A national survey of U.S. pharmacists in 2000: assessing nonresponse bias of a survey methodology.

AAPS pharmSci·2002
Same author

Perspectives on generic pharmaceuticals: some conclusions.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2002
Same author

Understanding the scientific issues embedded in the generic drug approval process.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2002
Same journal

The Sky is His Wife (2001)/Jim Alford (b. 1943).

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
Same journal

Zada Mary cooper (1875-1961).

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
Same journal

Aiming for, believing in, and achieving a target a1c of less than 7.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
Same journal

Evaluation of OTC Product Information in Three Drug Information Databases for PDAs.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
Same journal

New biotechnology approvals for 2002.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
Same journal

Preventing meningococcal outbreaks: an opportunity for pharmacists.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
See all related articles

Pharmacists face legal liability during drug product selection, including civil claims for negligence and criminal charges for fraud. While current liability is minimal, expanded roles may increase future legal risks.

Area of Science:

  • Pharmacy Law
  • Legal Medicine

Background:

  • Pharmacists' roles are expanding into drug product selection.
  • Understanding legal implications is crucial for practicing pharmacists.

Purpose of the Study:

  • To review the potential legal liability of pharmacists in drug product selection.
  • To analyze civil and criminal liability risks associated with generic substitution.

Main Methods:

  • Literature review of published articles from MEDLINE and law reviews.
  • Analysis of appellate court decisions related to pharmacist liability.
  • Searched using terms: pharmacist liability, drug product selection, generic substitution.

Main Results:

  • Pharmacists face civil liability via negligence, breach of warranty, and strict product liability.

Related Experiment Videos

  • Potential criminal liability includes insurance fraud and deceptive business practices.
  • Violation of state drug product selection laws also poses risks.

    • Conclusions:

    • Engaging in drug product selection slightly increases pharmacist liability.
    • Evolving legal landscape and expanded pharmacist roles suggest potential for increased future liability.
    • Courts may scrutinize expanded pharmacist responsibilities, impacting legal outcomes.